US FDA inspects Lupin’s Tarapur API facility
Rules out presence of NDMA impurity in co’s Valsartan, Losartan and Irbesartan APIs
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Priyanka Chopra partners with Cipla Respiratory to create awareness about asthma
Priyanka will help spread the word regarding the need for an attitudinal change towards inhalation therapy as the most effective…
TissUse establishes liver-endocrine tissues multi-organ model for risk assessment
TissUse will join forces with Bayer to develop a novel mechanistic in vitro assay that will allow assessment of species…
7th meeting of National Medicinal Plants Board held at New Delhi
The board also reviewed achievements in various sectors like cultivation, conservation, IEC, R&D etc.
AYUSH minister to inaugurate 4th International Ayurveda Congress at Netherlands
The congress would focus on promotion and propagation of Ayurveda in Netherlands and its neighbouring countries of Europe
Lupin receives FDA approval for generic Potassium Chloride Oral Solution USP
It is indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis
Zydus Cadila gets USFDA nod to market 2 products
Gemfibrozil tablets are used together with diet to treat very high cholesterol and triglyceride levels in people with…
AstraZeneca’s lupus drug fails to meet main goal in study
AstraZeneca's anifrolumab, which is given intravenously, was being developed for lupus, a chronic autoimmune disease with limited…
HC asks guilty pharma co to give ₹1.50 cr for Kerala flood relief
The court was hearing a suit filed by Glenmark Pharmaceuticals against Galpha Laboratories for allegedly infringing upon its…
Jiva Ayurveda, Gargi College, introduces six-month Ayurveda and Yoga course
The launch of the course in Gargi College is part of Jiva Ayurveda’s ongoing initiative to propagate the knowledge of Ayurveda…
Endothelial progenitor cells are safe for treating stroke patients, reveals study
Eighteen patients were recruited for the randomized, single-blinded study
Panacea Biotec inks Tripartite agreement with Natco Pharma, Breckenridge Pharmaceutical
As per the agreement the Panacea will manufacture and supply of Azacitidine injection in the US market
Lupin gets US FDA nod to market postherpetic neuralgia drug
The company's tablets are generic version of Pfizer Inc's Neurontin tablets in the same strengths
Cadila gets five observations from US FDA
The inspection was conducted at its subsidiary Liva Pharmaceuticals' injectables manufacturing facility in Vadodara
Suven secures product patents in China, Eurasia
The granted claims of the patents are being developed as therapeutic agents useful in the treatment of cognitive impairment…
Glenmark to market Tiotropium Bromide dry powder inhaler in Western Europe
Tiotropium Bromide DPI is a generic version of Boehringer Ingelheim's Spiriva Handihaler
Novartis wins EU approval for blood cancer therapy Kymriah
Novartis is investing 90 million Swiss francs ($90.4 million) in a new Swiss facility to produce Kymriah
Pfizer’s tafamidis reduces risk of death by 30 %, reveals study
The data was presented at the European Society of Cardiology Congress in Munich
3rd LOC meeting of 70th IPC was held at PHD chamber of commerce, New Delhi
BR Sikri informed that in the 2nd IPCA meeting held at Mumbai with Dilip Shanghavi, most of the points were discussed with regards…
Panacea inks pact with Natco, Breckenridge for cancer drug
Natco has provided the technology for manufacturing Azacitidine to Panacea Biotec's Baddi facility